Review a full credit report on Glaxosmithkline Pharmaceuticals, En Abrégé Glaxosmithkline for free now.
Access full report
How does Glaxosmithkline Pharmaceuticals, En Abrégé Glaxosmithkline compare to the averages within its industry.
Latest filings (2023)
Name | Currency | Share Count | Share Type | Nominal Value | % of Share Count |
---|---|---|---|---|---|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
hidden.hidden.hidden.hidden.hidden
|
Company | ||
---|---|---|
1968
|
||
1950
|
||
1983
|
||
1968
|
||
2012
|
||
2010
|
||
1968
|
||
1984
|
||
2005
|
||
1948
|
||
1961
|
||
2015
|
||
2019
|
||
1995
|
||
1969
|
||
2002
|